文献速递贫血与红细胞疾病白血病

RUNX1胚系突变致家族性血小板疾病伴髓系白血病倾向:一例报告及文献复习

[Familial platelet disorder with predisposition to myeloid leukemia (FPD/AML): a case report and literature review].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2021-01-01

报道1例5岁男童因血小板减少3年入院,检出RUNX1胚系移码突变,母亲及外祖父携带相同突变但临床表现不同;家族中5名成员患血液病并死亡。文献检索到37篇英文文献报道70多个FPD/AML家族,未检索到中文文献。

要点

  • RUNX1胚系突变是FPD/AML病因,进展为髓系恶性肿瘤风险极高。
  • 携带相同突变的家族成员临床表现和严重程度可差异显著。
  • 对血小板减少伴巨核系发育异常患儿应警惕FPD/AML并检测RUNX1胚系突变。

核心结论

  • RUNX1胚系突变导致FPD/AML,进展为髓系恶性肿瘤的风险极高。
  • 携带相同突变的家族成员可能表现出非常不同的临床症状和严重程度。

研究设计与样本

  • 对1例FPD/AML患儿及部分家族成员的临床资料和基因突变结果进行分析。
  • 以RUNX1胚系突变和FPD/AML为检索词检索中文数据库及PubMed至2020年9月。

主要发现

  • 患儿为5岁男孩,因血小板减少3年入院,体格检查示皮肤出血点。
  • 外周血常规示WBC 6.38×10(9)/L,HGB 113 g/L,PLT 54×10(9)/L,中性粒细胞绝对计数4.03×10(9)/L,MPV 9.1 fl。
  • 骨髓涂片提示巨核系发育异常,CD42b及CD41酶标提示存在小巨核细胞。
  • 基因检测提示RUNX1(exon3:c.520delC:p.R174Efs*10, NM_001001890)移码突变,经口腔上皮细胞验证为胚系突变。
  • 家族中共5名成员存在血液系统疾病并相继死亡;母亲及外祖父检测到相同位点RUNX1移码突变,但三人临床症状十分不同。

关键数值与推荐

  • 文献检索共检索到相关英文文献37篇,报道了70多个FPD/AML家族,未检索到相关中文文献。

临床怎么用

  • 对血小板减少伴巨核系发育异常的患儿,应结合家族史警惕FPD/AML并检测RUNX1胚系突变。
  • 对携带相同RUNX1突变的家族成员需进行个体化临床评估和随访。

局限性

  • 本文为单例报告及文献复习,未检索到相关中文文献。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To analyze the clinical features, bone marrow features, and gene mutations of children with familial platelet disorder with predisposition to myeloid leukemia (FPD/AML) caused by a RUNX1 germline mutation as well as their family members. Methods: The clinical data and gene mutations of a child with FPD/AML hospitalized in the Pediatric Blood Disease Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, and some family members were extracted and analyzed. The literature was searched using "RUNX1 germline mutation" and "FPD/AML" as keywords in the Chinese databases; also PubMed was reviewed until September 2020. Results: A male patient aged 5 with dermatorrhagia was admitted due to thrombocytopenia for more than 3 years. The laboratory tests revealed a peripheral blood routine (WBC 6.38×10(9)/L, HGB 113 g/L, PLT 54×10(9)/L, NEUT 4.03×10(9)/L, and MPV 9.1 fl) . Bone marrow smear revealed dysplasia of megakaryocytes. The immunohistochemistry for CD42b and CD41 highlighted small mononuclear megakaryocytes. Second generation sequencing revealed RUNX1 (exon3:c.520delC: p.R174Efs*10, NM_001001890) frameshift mutations, and its germline mutation was verified via genetic detection of oral epithelial cells. Five members of the family had blood diseases and successively died. The child's mother and maternal grandfather were sequenced for the second generation, and RUNX1 frameshift mutation was detected in the same locus as the child. However, the clinical features among them were different. A total of 37 English literatures were retrieved, and more than 70 FPD/AML families were reported. No relevant Chinese literature was retrieved. Conclusion: Runx1 germline mutations cause FPD/AML with a high risk of progression to myeloid malignancy. Family members carrying the same mutations may exhibit different clinical features and severity. 目的: 探讨RUNX1胚系突变导致的家族性血小板疾病并急性髓系白血病倾向(FPD/AML)患儿及其家族成员的临床特点及基因突变情况。 方法: 对2019年10月中国医学科学院血液病医院儿童血液诊疗中心收治的1例FPD/AML患儿及部分家族成员的临床资料及基因突变结果进行分析。并以"RUNX1胚系突变""家族性血小板疾病并急性髓系白血病倾向""RUNX1 germline mutation""FPD/AML"为检索词,检索建库至2020年9月中文数据库(中国知网数据库、万方数据库及维普数据库)及PubMed数据库进行文献复习。 结果: 患儿为5岁男孩,因发现血小板减少3年入院。体格检查提示存在皮肤出血点,其他无明显异常。辅助检查:外周血常规示WBC 6.38×10(9)/L,HGB 113 g/L,PLT 54×10(9)/L,中性粒细胞绝对计数4.03×10(9)/L,血小板平均体积(MPV)9.1 fl。骨髓涂片提示巨核系发育异常。涂片免疫CD42b及CD41酶标提示存在小巨核细胞。基因检测提示RUNX1(exon3:c.520delC:p.R174Efs*10, NM_001001890)的移码突变,经口腔上皮细胞验证为胚系突变。家族史中共有5名家族成员存在血液系统疾病并相继死亡。患儿母亲及外祖父先后进行了与血液肿瘤疾病相关的137个基因热点区域的基因检测,均检测到与患儿相同位点的RUNX1移码突变,但是三人的临床症状十分不同。文献检索共检索到相关英文文献37篇,报道了70多个FPD/AML家族,未检索到相关中文文献。 结论: RUNX1胚系突变是导致FPD/AML的病因,进展为髓系恶性肿瘤的风险极高,携带相同突变的家族成员可能表现出非常不同的临床症状和严重程度。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhang RR, Chen XJ, Ren YY, et al. [Familial platelet disorder with predisposition to myeloid leukemia (FPD/AML): a case report and literature review]. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 33979975. doi:10.3760/cma.j.issn.0253-2727.2021.04.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。